新癀片致药品不良反应分析

doi:10.19803/j.1672-8629.2022.05.19

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (5): 561-563.
DOI: 10.19803/j.1672-8629.2022.05.19

新癀片致药品不良反应分析

张瑞丽, 苏爽, 蒋季明^*, 张婧

中国中医科学院望京医院药学部, 北京100102

收稿日期:2020-07-29 出版日期:2022-05-15 发布日期:2022-05-18
通讯作者: ^*蒋季明,女,本科,主管药师,中药临床药学。E-mail：mm7766@sohu.com
作者简介:张瑞丽,女,本科,主管药师,临床药学。
基金资助:
2018级全国中药特色技术传承人才培训项目（T20184828005）

Thirty-six cases of adverse drug reactions/events caused by Xinhuang tablets

ZHANG Ruili, SU Shuang, JIANG Jiming^*, ZHANG Jing

Department of Pharmacy, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China

Received:2020-07-29 Online:2022-05-15 Published:2022-05-18

摘要/Abstract

摘要： 目的对新癀片不良反应（ADR）发生情况进行回顾分析,为临床合理用药提供参考。方法以“新癀片”“不良反应”“引起”“致”为检索词,检索中国知网、万方数据、维普网,检索时间为建库至2020年4月30日,对收录的新癀片ADR文献进行筛选和分析。结果研究纳入文献24篇,涉及病例36例,新癀片ADR累及系统-器官最常见的为神经系统损害、胃肠损害、全身性损害,主要ADR表现为恶心、呕吐、头晕、头痛、胸闷等,严重者可见过敏性休克。结论关注新癀片ADR,加强临床合理用药指导,确保用药安全。

关键词: 新癀片, 药品不良反应, 文献分析, 中成药

Abstract: Objective To retrospectively analyze ADR induced by Xinhuang tablets in order to provide reference for rational use of this drug in clinic.Methods?With?"Xinhuang tablets",?"adverse reaction" or "cause" as the key words, related articles were retrieved from the CNKI, Wanfang database and VIP Chinese full-text database that had been published from the inception to April 30, 2020. Literature related to ADR induced by Xinhuang tablets was screened and analyzed.?Results?Twenty-four articles were included, involving 36 cases of adverse drug reactions. The dominating adverse reactions were manifested as neurological damage, gastrointestinal damage and systemic damage. Common symptoms included nausea, vomiting, dizziness, headache and chest distress. Anaphylactic shock, which was life threatening, was also reported in severe cases. Conclusion It is important that clinicians and patients become aware of ADR induced by Xinhuang tablets. Precaution should be taken to ensure the safe use of this drug.

Key words: Xinhuang tablets, adverse drug reaction, literature review, Chinese patent medicine

中图分类号:

R994.11

张瑞丽, 苏爽, 蒋季明, 张婧. 新癀片致药品不良反应分析[J]. 中国药物警戒, 2022, 19(5): 561-563.

ZHANG Ruili, SU Shuang, JIANG Jiming, ZHANG Jing. Thirty-six cases of adverse drug reactions/events caused by Xinhuang tablets[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 561-563.

参考文献

[1] Chinese Pharmacopoeia Commission.Chinese Pharmacopeia Guidelines for Clinical Drug Use of TCM Prescription Preparation Volume(中华人民共和国药典临床用药须知:中药成方制剂卷)[M]. 2015 ed. Beijing: China Medical Science and Technology Press, 2017: 951.
[2] CHEN JZ, XU YQ, TANG Z, et al.Acute renal injury and leukopenia induced by acyclovir combined with Xinhuang tablets: a case report[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2019, 28(12): 836-838.
[3] MAI MJ, WANG F.A case of anaphylactic shock caused by oral compound Aminopyrine tablets and Xinhuang tablets[J]. Xinjiang Journal of Traditional Chinese Medicine(新疆中医药), 2002, 20(1): 28.
[4] CHEN LH, WANG DJ.A case of stomach noise and tongue ulcer caused by Niuhuangjiedu tablet and Xinhuang tablet[J]. Seek Medical and Ask The Medicine(求医问药), 2012, 10(9): 280.
[5] LIN YM.6 cases of drug-induced gastric bleeding caused by Xinhuang tablets[J]. World Chinese Journal of Digestion(华人消化杂志), 1998, 6(S2): 390.
[6] PAN J.A case of drowsiness caused by Xinhuang tablet[J]. Journal of Navy Medicine(海军医学杂志), 2013, 34(4): 261.
[7] SUN YY.The nursing experience of a case of oral Xinhuang tablets caused allergic asthma[J]. Chinese Journal of Modern Drug Application(中国现代药物应用), 2015, 9(18): 186-187.
[8] ZHANG H, MAO WZ.A case report of asphyxia-like asthma caused by oral administration of Xinhuang tablets[J]. Fujian Journal of Traditional Chinese Medicine(福建中医药), 1997, 28(2): 48.
[9] CHEN DH.A case report of angioedema caused by Xinhuang tablet[J]. Chinese Practical Journal of Rural Doctor(中国实用乡村医生杂志), 2005, 12(8): 50.
[10] GUO JH.A case of anaphylactic shock caused by taking Xinhuang tablets on an empty stomach[J]. Journal of Handan Medical College(邯郸医学高等专科学校学报), 2001, 14(2): 116-117.
[11] HU QQ.Nursing care of a patient whose body temperature does not rise due to Xinhuang tablets[J]. Chinese Nursing Research(护理研究), 2011, 25(30): 2819-2820.
[12] PU YJ, ZHAO YJ, WU FB, et al.Literature analysis of 137 ADR induced by indometacin oral preparation[J]. China Pharmacy(中国药房), 2010, 21(36): 3435-3436.
[13] LIU J, DI ZQ, WANG JJ, et al.Mechanism of Chinese herbal ingredients in Xinhuang tablet on attenuating gastrointestinal toxicity induced by indomethacin[J]. Chinese Traditional and Herbal Drugs(中草药), 2014, 45(8): 1115-1120.
[14] CHEN XQ, JIN YY, TANG G.New edition of Pharmacology(新编药物学)[M]. Beijing: People's Medical Publishing House, 2011: 186-187.
[15] WANG LJ, XIE TY.3 cases of anaphylactic shock caused by Zhongjiefeng injection[J]. Medical Journal of Chinese People's Health(中国民康医学), 2007, 19(3): 235.
[16] YUAN XJ, LI PL.A case of anaphylactic shock caused by indomethacin[J]. People's Military Surgeon, 2016, 59(9): 899.
[17] XIE WY.2 cases of allergic reactions caused by Xinhuang tablets[J]. Journal of Practical Traditional Chinese Medicine(实用中医药杂志), 2002, 18(1): 54.
[18] LIN Z.2 cases of allergic asthma caused by Xinhuang tablets[J]. Chinese Journal of Coal Industry Medicine(中国煤炭工业医学杂志), 2005, 8(7): 679.
[19] LIN WM.4 cases of reactions by oral administration of Xinhuang tablets[J]. Fujian Journal of Traditional Chinese Medicine(福建中医药), 1984(3):39.
[20] BIAN BY, SHAO R, CHEN YF, et al.Meta-analysis of the indications of Xinhuang tablets[J]. China Journal of Pharmaceutical Economics(中国药物经济学), 2007, 15(4): 37-42.
[21] LU HS, GAN JB, CHEN ZY, et al.Clinical application of Xinhuang tablets in dermatology[J]. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine(浙江中西医结合杂志), 2015, 25(1): 102-104.

新癀片致药品不良反应分析

Thirty-six cases of adverse drug reactions/events caused by Xinhuang tablets

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[9]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[10]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[11]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[12]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.
[13]	里筱竹, 王蔷, 逄瑜, 张轶菁. 个例药品不良反应报告管理浅析与思考[J]. 中国药物警戒, 2023, 20(9): 975-977.
[14]	逄瑜, 刘博, 吕少俐, 王涛, 邢颖, 秦星宇, 田月洁, 吴文宇. 基于国际药物警戒经验探讨收集患者报告的意义[J]. 中国药物警戒, 2023, 20(9): 978-981.
[15]	刘文东, 崔欢欢, 王晓晗, 苏娴, 王海学. 我国儿童用药临床试验期间药物警戒监管体系现状及思考[J]. 中国药物警戒, 2023, 20(9): 1002-1006.